Guarding Health Through Vigilance
Comprehensive safety monitoring and risk management throughout the entire product lifecycle, from clinical development to post-marketing surveillance.
Integrated safety monitoring and risk management across the product lifecycle
Provaxa provides comprehensive pharmacovigilance services that systematically monitor, detect, assess, and prevent adverse drug reactions and related problems throughout a product's lifecycle. From clinical development through post-approval, we integrate data collection, risk assessment, and transparent communication to minimize risks while maximizing therapeutic benefits.
Our pharmacovigilance experts strengthen the understanding of drug safety, contributing to improved regulatory standards and enhanced patient care. We maintain ICH-GCP compliance, ISO-certified quality systems, and proven expertise navigating complex global regulatory environments.
We support pharmaceutical companies in maintaining compliance, enhancing drug safety, and accelerating regulatory approvals across CDSCO, EMA, US FDA, and other global pathways.
Pharmacovigilance is integral to identifying, evaluating, and managing risks during clinical trials and post-approval. It enables early detection of adverse drug reactions (ADRs), ensures the balance of benefit versus risk is continually reassessed as new safety data emerges, facilitates compliance with regulatory requirements, and ultimately protects patient welfare while accelerating approval timelines.
Comprehensive safety solutions across the entire product lifecycle
End-to-end management of adverse event (AE) and serious adverse event (SAE) collection, processing, and reporting. We ensure timely, accurate submissions to regulatory authorities while maintaining full compliance with safety reporting timelines.
Systematic identification and evaluation of new or emerging safety risks through advanced data analytics and rigorous scientific assessment. We develop comprehensive risk management plans (RMPs) and safety strategies tailored to your product's safety profile.
Establishment, maintenance, and optimization of safety databases for complete AE/SAE tracking and Individual Case Safety Report (ICSR) management. Secure data storage, quality assurance, and regulatory audit readiness.
Comprehensive preparation and submission of periodic safety update reports (PSURs), development safety update reports (DSURs), and annual safety reports. Full compliance with ICH guidelines and regional regulatory requirements.
Establishment and operational support of independent Data Safety Monitoring Boards (DSMB) and Safety Monitoring Committees. We provide meeting coordination, safety reports, risk assessment documentation, and regulatory compliance.
Development, maintenance, and updates of comprehensive Pharmacovigilance System Master Files. Complete documentation of your pharmacovigilance systems, processes, and quality assurance measures for regulatory submissions and inspections.
Our pharmacovigilance systems integrate real-time safety data analytics, automated signal detection algorithms, and predictive risk modeling to identify emerging safety signals early, enabling faster decision-making and enhanced patient protection.
Deep knowledge and proven track record across global regulatory requirements
Provaxa maintains comprehensive expertise in pharmacovigilance requirements across all major global regulatory authorities. Our team has extensive experience navigating CDSCO (Central Drugs Standard Control Organisation), EMA (European Medicines Agency), US FDA (Food and Drug Administration), and other regional regulatory pathways.
We understand the nuanced differences in pharmacovigilance expectations across jurisdictions and ensure your safety monitoring strategies align with each region's specific requirements. Our proactive regulatory engagement helps sponsors anticipate requirements, streamline submissions, and accelerate approval timelines.
Key Regulatory Focus Areas:
Our ISO-certified quality systems and proven compliance record ensure your pharmacovigilance program meets all regulatory expectations. We maintain detailed audit trails, comprehensive documentation, and robust quality control measures to support regulatory inspections and submissions with confidence.
Proven expertise delivering superior patient safety outcomes and regulatory compliance
Deep knowledge of ICH-GCP, EMA, US FDA, and CDSCO pharmacovigilance requirements with proven track record of first-cycle approvals and zero compliance issues.
Safety monitoring strategies designed with patient welfare as the paramount concern, ensuring rapid identification and communication of emerging safety signals.
State-of-the-art safety data management systems with automated signal detection algorithms enabling faster identification of emerging safety risks.
End-to-end pharmacovigilance support from database setup and ICSR management to periodic reports, RMP development, and PSMF maintenance.
Qualified safety professionals, pharmacists, and medical monitors with extensive experience across therapeutic areas and regulatory submissions.
ISO-certified quality systems, ICH-GCP compliance, and proven experience managing multi-regional pharmacovigilance programs across diverse regulatory landscapes.
Partner with Provaxa for comprehensive pharmacovigilance services that ensure drug safety, regulatory compliance, and patient-focused outcomes throughout your product's lifecycle.
Provaxa is proudly powered by WordPress